RADIOLOGICAL DIAGNOSTIC OF APICAL FORM OF HYPERTROPHIC CARDIOMYOPATHY
https://doi.org/10.22328/2079-5343-2018-4-68-73
Abstract
Hypertrophic cardiomyopathy affects about 0,2% of the adult population of the Earth. This disease is one of the main causes of sudden death, and can also lead to disability in patients of all age groups, which determines the high medical and social significance of the disease. Echocardiography and magnetic resonance imaging are the most informative methods of radiological diagnostics of hypertrophic cardiomyopathy.
About the Authors
I. E. Obramenko
Volgograd Regional Clinical Cardiological Center
Russian Federation
Volgograd
Russian Federation
Volgograd
D. I. Zenchenko
Volgograd State Medical University
Russian Federation
Volgograd
Russian Federation
Volgograd
References
1. Roytberg G.E., Strutynskiy A.V. Vnutrenniye bolezni. Serdechno-sosudistaya sistema, Moscow: Izdatel’stvo Binom-press, 2007, 856 p. (In Russ.).
2. 2014 ECS Guidelines on diagnosis and management of hypertrophic cardiomyopathy // EHJ. 2014. No. 35. P. 2733−2779. Doi:10.1093/eurheartj/ehu284.
3. Daubeney P.E., Nugent A.W., Chondros P., Carlin J.B. et al. Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy. Results From a National Population-Based Study // Circulation. 2006. Vol. 114, No. 24. Р. 2671−2678.
4. Bevilacqua L.М., Berul Ch.I. Familial Hypertrophic Cardiomyopathy Genetics // Molecular Genetics of Cardiac Electrophysiology. 2000. Vol. 231. Р. 181–194. Doi: 10.1007/978- 1-4615-4517-0.
5. Bos J.M., Towbin J.A., Ackerman M.J. Diagnostic, prognostic and therapeutic implications of genetic testing for hypertrophic cardiomyopathy // JACC. 2009. No. 54. Р. 201−211.
6. Marian A. J., Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy // J. Mol. Cell. Cardiol. 2001. No. 33. Р. 655–670.
7. Sherkhova M.H., Stukalova O.V., Ternovoy S.K. Apical hypertrophic cardiomyopathy. Diagnosis by magnetic resonance imaging, REJR, 2014, Vol. 4, No. 3, pp. 77−80 (In Russ.).
8. Maron B.J. Hypertrophic cardiomyopathy a systematic review // JAMA. 2002. No. 287. Р. 1308−1320.
9. Reddy V., Korcarz C., Weinert L. et al. Apical. hypertrophic cardiomyopathy // Circulation. 1998. Р. 2354. Doi: http://dx.doi.org/10.1161/ 01.CIR.98.21.2354.
10. Dastidar A.G., Singhal P., Venuti G. et al. Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM) // JCMR. 2016. Vol. 18 (Suppl 1). P. 269.
11. Clinical guidelines for the diagnosis and treatment of cardiomyopathy (hypertrophic). Kardiologicheskiy vestnik, 2016, Vol. XI, No. 1, pp. 3−23 (In Russ.).
12. Evangelista A., Frank Flachskampf F., Lancellotti P. et al. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies // EHJ. Cardiovascular Imaging. 2008. Vol. 9, No. 4. Р. 438−448.
13. Hamada М., Takamura Y., Otani T. et al. Left ventricular noncompaction mimicking hypertrophic obstructive cardiomyopathy // Int. J. Cardiol. 2016. No 220. Р. 825–827.
14. Maron B.J., McKenna W.J., Danielson G.K. et al. ACC/ESC Expert Consensus Document on Hypertrophic Cardiomyopathy // JACC. 2003. Vol. 42, No. 9. Р. 1687–1713.
15. Moon J.C., Fisher N.G., McKenna W.J., Pennell D.J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography // Heart. 2004. No. 90. Р. 645−649
Review
For citations:
Obramenko I.E., Zenchenko D.I. RADIOLOGICAL DIAGNOSTIC OF APICAL FORM OF HYPERTROPHIC CARDIOMYOPATHY. Diagnostic radiology and radiotherapy. 2018;(4):68-73. (In Russ.) https://doi.org/10.22328/2079-5343-2018-4-68-73
Views:
756
Email this article 